1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cognitive Assessment and Training in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cognitive Assessment and Training in Healthcare Market, by Assessment Type
8.1.1. Pen & Paper-Based Assessment
8.1.1.1. Market Revenue and Forecast
8.1.2. Biometrics Assessment
8.1.2.1. Market Revenue and Forecast
8.1.3. Hosted/Digital Assessment
8.1.3.1. Market Revenue and Forecast
9.1. Cognitive Assessment and Training in Healthcare Market, by Component
9.1.1. Services
9.1.1.1. Market Revenue and Forecast
9.1.2. Solutions
9.1.2.1. Market Revenue and Forecast
10.1. Cognitive Assessment and Training in Healthcare Market, by Application
10.1.1. Clinical Trials
10.1.1.1. Market Revenue and Forecast
10.1.2. Screening & Diagnostics
10.1.2.1. Market Revenue and Forecast
10.1.3. Brain Training
10.1.3.1. Market Revenue and Forecast
10.1.4. Academic Research/Others
10.1.4.1. Market Revenue and Forecast
11.1. Cognitive Assessment and Training in Healthcare Market, by End-User (Typical Healthcare Focus)
11.1.1. Hospitals & Healthcare Providers
11.1.1.1. Market Revenue and Forecast
11.1.2. Home Care/Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Rehabilitation Centers & Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Assessment Type
12.1.2. Market Revenue and Forecast, by Component
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Assessment Type
12.1.5.2. Market Revenue and Forecast, by Component
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Assessment Type
12.1.6.2. Market Revenue and Forecast, by Component
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Assessment Type
12.2.2. Market Revenue and Forecast, by Component
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Assessment Type
12.2.5.2. Market Revenue and Forecast, by Component
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Assessment Type
12.2.6.2. Market Revenue and Forecast, by Component
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Assessment Type
12.2.7.2. Market Revenue and Forecast, by Component
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Assessment Type
12.2.8.2. Market Revenue and Forecast, by Component
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Assessment Type
12.3.2. Market Revenue and Forecast, by Component
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Assessment Type
12.3.5.2. Market Revenue and Forecast, by Component
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Assessment Type
12.3.6.2. Market Revenue and Forecast, by Component
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Assessment Type
12.3.7.2. Market Revenue and Forecast, by Component
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Assessment Type
12.3.8.2. Market Revenue and Forecast, by Component
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Assessment Type
12.4.2. Market Revenue and Forecast, by Component
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Assessment Type
12.4.5.2. Market Revenue and Forecast, by Component
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Assessment Type
12.4.6.2. Market Revenue and Forecast, by Component
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Assessment Type
12.4.7.2. Market Revenue and Forecast, by Component
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Assessment Type
12.4.8.2. Market Revenue and Forecast, by Component
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Assessment Type
12.5.2. Market Revenue and Forecast, by Component
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Assessment Type
12.5.5.2. Market Revenue and Forecast, by Component
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Assessment Type
12.5.6.2. Market Revenue and Forecast, by Component
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End-User (Typical Healthcare Focus)
13.1. Cambridge Cognition Ltd
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. CogniFit Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Cogstate Ltd
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. CNS Vital Signs, LLC
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. ImPACT Applications Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Quest Diagnostics Incorporated
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Signant Health
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Posit Science
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. BracketHQ
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Neurocog Trials
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
